Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia

References

• Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129(6):1432–1440.
   PubMed Web of Science ®Google Scholar
• Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Gonçalves VM. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect. 2004;10(6):542–549.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, et al. 2002Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34(6):730–751.
   PubMed Web of Science ®Google Scholar
• Butt T, Afzal RK, Ahmad RN, Salman M, Mahmood A, Anwar M. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern. J Ayub Med Coll Abbottabad. 2004;16(1):18–22.
   PubMedGoogle Scholar
• Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis. 2004;39(Suppl 1):S25–S31.
   PubMedGoogle Scholar
• Rolston KV, Bodey GP. Bacterial infections in cancer patients. In: Lyman GH, Crawford J, editors. Cancer Supportive Care: Advances in Therapeutic Strategies. New York: Informa Healthcare; 2008:73–88.
   Google Scholar
• Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis. 1999;29(3):490–494.
   PubMed Web of Science ®Google Scholar
• Oppenheim BA. The changing pattern of infection in neutropenia patients. J Antimicrob Chemother. 1998;41(Suppl 4):7–11.
   PubMedGoogle Scholar
• Silva V, Díaz MC, Febré N. Invasive fungal infections in Chile: a multicenter study of fungal prevalence and susceptibility during a 1-year period. Med Mycol. 2004;42(4):333–339.
   PubMed Web of Science ®Google Scholar
• Horn DL, Morrison DC, Opal SM, Silverstein R, Visvanathan K, Zabriskie JB. What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium. Clin Infect Dis. 2000;31(4):851–858.
   Google Scholar
• Pasqualotto AC, Rosa DD, Medeiros LR, Severo LC. Candidaemia and cancer: patients are not all the same. BMC Infect Dis. 2006;6:1.
   PubMed Web of Science ®Google Scholar
• Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20(15):3276–3281.
   PubMed Web of Science ®Google Scholar
• Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244(5):379–386.
   PubMed Web of Science ®Google Scholar
• Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia. Cancer. 2004;100(2):228–237.
   PubMed Web of Science ®Google Scholar
• Cebon J, Layton JE, Maher D, Morstyn G. Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol. 1994;86(2):265–274.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56–e93.
   PubMed Web of Science ®Google Scholar
• Montassier E, Batard E, Gastinne T, Potel G, de la Cochetière MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32(7):841–850.
   PubMed Web of Science ®Google Scholar
• Arega B, Wolde-Amanuel Y, Adane K, Belay E, Abubeker A, Asrat D. Rare bacterial isolates causing bloodstream infections in Ethiopian patients with cancer. Infect Agent Cancer. 2017;12:40.
   PubMed Web of Science ®Google Scholar
• Mikulska M, Viscoli C, Orasch C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2014;68(4):321–331.
   PubMed Web of Science ®Google Scholar
• Islas-Muñoz B, Volkow-Fernández P, Ibanes-Gutiérrez C, Villamar-Ramírez A, Vilar-Compte D, Cornejo-Juárez P. Bloodstream infections in cancer patients: risk factors associated with mortality. Int J Infect Dis. 2018;71:59–64.
   PubMed Web of Science ®Google Scholar
• Gedik H. Antibiotic resistance status and its costs in hematological patients: a two-year analysis. Caspian J Intern Med. 2017;8(4):276–281.
   PubMedGoogle Scholar
• Raja NS, Gupta S, O’Neill B. Bacterial spectrum and antimicrobial-resistance pattern of bloodstream infections in neutropenic and non-neutropenic adult cancer patients. J Patient Saf Infect Control. 2017;5(2):83–88.
   Google Scholar
• Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Res Notes. 2015;8:742.
   PubMedGoogle Scholar
• Mangaraj J, Barkataki D. Microbiological profile of blood stream infection in neutropenic patient in a tertiary care centre. Int J Curr Microbiol App Sci. 2017;6(3):1137–1145.
   Google Scholar
• Mangaraj O, Barkataki D, Mohan DG. Gram negative bacilli causing blood stream infection in febrile neutropenic patients in a tertiary care centre. Int J Contemp Med Res. 2017;4(7):1599–1603.
   Google Scholar
• Kurtaran B, Candevir A, Tasova Y, et al. Hospital-acquired blood-stream infections in cancer patients between 2005 and 2007 in a Turkish university hospital. Arch Clin Microbiol. 2010;1(2):4.
   Google Scholar
• O’Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ. Infections in patients with hematological cancer: recent developments. Hematology Am Soc Hematol Educ Program. 2003;2003(1):438–472.
   Google Scholar
• Rolston KV. Bacterial infection in neutropenic cancer patients: an overview. Iran J Clin Infect Dis. 2009;4(2):115–122.
   Google Scholar
• Elseed Y, Ibrahim M, Ahmed WA. Isolation and identification of aerobic bacterial pathogens from septicaemic cancer patients in Khartoum, Sudan. Clin Med J. 2015;1(4):122–125.
   Google Scholar
• Mutnick AH, Kirby JT, Jones RN. Cancer Resistance Surveillance Program: initial results from hematology–oncology centers in North America. Ann Pharmacother. 2003;37(1):47–56.
   PubMed Web of Science ®Google Scholar
• Kanamaru A, Tatsumi Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis. 2004;39(Suppl 1):S7–S10.
   PubMedGoogle Scholar
• Nejad ZE, Ghafouri E, Farahmandi-Nia Z, Kalantari B, Saffari F. Isolation, identification, and profile of antibiotic resistance of bacteria in patients with cancer. Iran J Med Sci. 2015;35(2):109–115.
   Google Scholar
• Louw VJ, van der Westhuizen J, Rautenbach W, van der Berg E, Wamelink M, Joubert G. The antibiotic susceptibility of bacteria isolated from blood cultures during episodes of neutropenic fever in patients with myeloid leukaemia. South Afr J Epidemiol Infect. 2010;25(2):9–11.
   Google Scholar
• Baskaran ND, Gan GG, Adeeba K, Sam IC. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Int J Infect Dis. 2007;11(6):513–517.
   PubMed Web of Science ®Google Scholar
• Ashour HM, el-Sharif A. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients. J Clin Oncol. 2007;25(36):5763–5769.
   PubMed Web of Science ®Google Scholar
• Chen CY, Tang JL, Hsueh PR, et al. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J Formos Med Assoc. 2004;103(7):526–532.
   PubMed Web of Science ®Google Scholar
• Zahid KF, Hafeez H, Afzal A. Bacterial spectrum and susceptibility patterns of pathogens in adult febrile neutropenic patients: a comparison between two time periods. J Ayub Med Coll Abbottabad. 2009;21(4):146–149.
   PubMedGoogle Scholar
• Saghir S, Faiz M, Saleem M, Younus A, Aziz H. Characterization and anti-microbial susceptibility of Gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. Indian J Med Microbiol. 2009;27(4):341–347.
   PubMed Web of Science ®Google Scholar
• Abebe FA, Berhe DF, Berhe AH, Hishe HZ, Akaleweld MA. Drug use evaluation of ceftriaxone: the case of Ayder Referral Hospital, Mekelle, Ethiopia. Int J Pharm Sci Res. 2012;3(7):2191–2195.
   Google Scholar
• Rolston KV. Bacterial infection in neutropenic cancer patients: an overview. Arch Clin Infect Dis. 2009;4(2):115–122.
   Google Scholar
• Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents. 2005;25(2):95–109.
   PubMed Web of Science ®Google Scholar
• Velasco E, Thuler LC, Martins CA, et al. Epidemiology of bloodstream infections at a cancer center. Sao Paulo Med J. 2000;118(5):131–138.
   PubMedGoogle Scholar
• de Oliveira-Garcia D, dall’Agnol M, Rosales M, et al. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol. 2003;5(9):625–636.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28(5):1071–1079.
   PubMed Web of Science ®Google Scholar
• Tuon FF, Costa SF. Rhodotorula infection: a systematic review of 128 cases from literature. Rev Iberoam Micol. 2008;25(3):135–140.
   PubMed Web of Science ®Google Scholar
• Royo-Cebrecos C, Gudiol C, Ardanuy C, Pomares H, Calvo M, Carratalà J. A fresh look at polymicrobial bloodstream infection in cancer patients. PLoS One. 2017;12(10):e0185768.
   PubMed Web of Science ®Google Scholar
• Gudiol C, Tubau F, Calatayud L, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66(3):657–663.
   PubMed Web of Science ®Google Scholar
• Pagano L, Tacconelli E, Tumbarello M, et al. Bacteremia in patients with hematological malignancies: analysis of risk factors, etiological agents and prognostic indicators. Haematologica. 1997;82(4):415–419.
   PubMed Web of Science ®Google Scholar
• Swati M, Gita N, Sujata B, Farah J, Preeti M. Microbial etiology of febrile neutropenia. Indian J Hematol Blood Transfus. 2010;26(2):49–55.
   PubMed Web of Science ®Google Scholar
• Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia. Cancer. 2004;100(2):228–237.
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Steckelberg JM, Cockerill FR, Sauver JL, Wilson WR, Baddour LM. Age and sex associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med. 2007;167(8):834–839.
   PubMedGoogle Scholar